The lack of neuroprotective effect upon chronic chemogenetics may be attributed to the complex intricacies of this study, including established hurdles of chronic neuromodulation, neurotrophic factor signaling, treatment strategies in glaucoma research, or a combination thereof. The gene discussed is NTF3; the disease is glaucoma.